Larvol Delta - Inhibikase-Therapeutics-Initiates-Medical-and-Patient-Awareness-Campaign-for-its-Phase-2-3920139-Trial-Evaluating-IkT148009-in-Parkinson39s-Disease

IkT-148009 - Inhibikase, Clintrex

https://www.prnewswire.com/news-releases/inhibikase-therapeutics-initiates-medical-and-patient-awareness-campaign-for-its-phase-2-201-trial-evaluating-ikt-148009-in-parkinsons-disease-301856071.html

Jun 21, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next